View of EARLY MOLECULAR AND IMMUNE MARKERS AS A BASIS FOR DIFFERENTIATED THERAPY OF TYPE 2 AUTOIMMUNE POLYGLANDULAR SYNDROME (LITERATURE REVIEW)

Return to Article Details EARLY MOLECULAR AND IMMUNE MARKERS AS A BASIS FOR DIFFERENTIATED THERAPY OF TYPE 2 AUTOIMMUNE POLYGLANDULAR SYNDROME (LITERATURE REVIEW) Download Download PDF